Register | Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC

Specialties >>

AML
Biomarker-Driven Lung Cancer
Bladder Cancer
Breast Cancer
CAR T-Cell Therapy
CLL
Colorectal Cancer
DLBCL
EGFR+ Lung Cancer
Follicular Lymphoma
Genomic Testing
GI Cancers
Gynecologic Cancers
HCC
Hematology
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Skin Cancers
Thyroid Cancers
More >>

Partners >>

Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up

Evolving Paradigms

2019  |  2018  |  2017  |  2016  |  2015


Recent Advances in the Treatment of Chronic Lymphocytic Leukemia


Tropomyosin Receptor Kinase as a Target for the Treatment of Solid Tumors


Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia


Ovarian Suppression in Breast Cancer


Chronic Lymphocytic Leukemia


Cutaneous Squamous Cell Carcinoma


Role of Immunotherapy in NSCLC


Mantle Cell Lymphoma


Breast Cancer: Focus on CDK4&6 Inhibitors


Immunotherapy in Nonsquamous Non-Small Cell Lung Cancer


Non-Small Cell Lung Cancer


Soft Tissue Sarcoma


Clinical Advances in Prostate Cancer


Triple Negative Breast Cancer


Pancreatic Cancer


BRAF-Mutant Melanoma


CDK4&6 Inhibition


Sequencing Strategies in Prostate Cancer


Bladder Cancer


Immuno-Oncology: Checkpoint Inhibitors


Lymphoma


Squamous NSCLC


Gynecologic Cancer
Copyright © TargetedOnc 2020 Intellisphere, LLC. All Rights Reserved.